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Abstract
Background: According to US-EPA report, the use of pyrethrins and pyrethroids has increased during the past
decade, and their area of use included not only in agricultural settings, but in commerce, and individual household.
It is known that urinary 3-PBA, major metabolite of pyrethroid, have some associations with health effect in nervous
and endocrine system, however, there’s no known evidence that urinary 3-PBA have associations with obesity.
Method: We used data of 3671 participants aged above 19 from the Korean National Environmental Health Survey
in 2009–2011. In our analysis, multivariate piece-wise regression and logistic regression analysis were used to
investigate the association between urinary 3-PBA (3-Phenoxybenzoic Acid) and BMI.
Result: Log-transformed level of urinary 3-PBA had significantly positive association with BMI at the low-level range
of exposure (p < 0.0001), and opposite associations were observed at the high level exposure (p = 0.04) after adjusting
covariates. In piece-wise regression analysis, the flexion point that changes direction of the associations was at around
4 ug/g creatinine of urinary 3-PBA. As quintiles based on concentration of urinary 3-PBA increased to Q4, the ORs for
prevalence of overweight (BMI≥ 23 kg/m2) were increased, and the OR of Q5 was lower than that of Q4 (OR = 1.810
for Q4; OR = 1.483 for Q5). In the analysis using obesity (BMI≥ 25 kg/m2) as outcome variable, significant associations
were observed between obesity and quintiles of 3-PBA, however, there were no differences between the OR of Q5 and
that of Q4 (OR = 1.659 for Q4; OR = 1.666 for Q5).
Conclusion: Our analysis suggested that low-level of pyrethroid exposure has positive association with BMI, however,
there is an inverse relationship above the urinary 3-PBA level at 4 ug/g creatinine.
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Background
Pesticide, including insecticide, usage is increasing since
the past decades. According to U.S. EPA, the amount of
global pesticide use in 2007 was about 5.2 billion pounds
[1], which reflects a 700 % rise, as compared to 1960s.
The pesticide usage in South Korea has also dramatically
increased about 20 times during the last 50 years [2],
and their field of use includes both agricultural and
urban areas.
Pyrethroid, a synthetic chemical insecticide derived
from pyrethrins, has been widely used since 1980s be-
cause of its effectiveness and low toxicity, as compared
to other insecticides such as organophosphorus and car-
bamic ester compounds. However, similar to other insec-
ticides, pyrethroid insecticides have toxic effects on the
nervous system in the body [3, 4]. They act by altering
the permeability of sodium ion channels in excited nerve
cells [5]. However, distinct from insects, mammals rap-
idly and enzymatically metabolize pyrethroid insecticides
and excrete the metabolites, so that they have lower tox-
icity to pyrethroid insecticide [6]. Consequently, pyreth-
roid insecticides in global market comprise more than
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30 %, moreover, they are the most widely used agents
for indoor pest control [7].
Despite their less toxic effect to human health, recent
research revealed that even low-level exposure to pyre-
throids also have adverse effects on not only the nervous
system but also other systems in humans. There are
some reports about immunologic response associated
with exposure to pyrethroid [8, 9], behavioral problems
in children [10], and neural and mental development of
infants who are exposed in the prenatal period [11].
Additionally, some animal studies suggested that the
possibility of harmfulness to other systems, including
the hepatic system and thyroid [12]. Recently, some ani-
mal studies showed body weight change after pyrethroid
exposure, as high level exposure was related to de-
creased body weight or lack of suitably increased body
weight [12].
Some studies reported that the relationships between
endocrine disrupting chemicals and body weight change
might be non-monotonous [13–16]. Especially, the results
from some persistent organic pollutants (POPs) showed
inverted U-shaped curves with many health outcomes such
as type 2 diabetes, dyslipidemia, or weight gain [13, 14, 17].
We aimed to examine the association between pyrethroid
exposure and obesity in a national representative cross-
sectional study. In addition, we evaluated the differences in
the association between pyrethroid exposure and obesity
depending on the exposure levels.
Methods
Ethics statement
This study was approved by the Institutional Review
Board of Seoul National University Hospital (IRB No.
1504-077-665), and when 1st KNEHS was conducted,
written informed consent was obtained from all subjects.
Study participants
We used the data from the 1st Korean National Environ-
mental Health Survey (KNEHS), which was conducted
by National Institute of Environmental Research (NIER)
from 2009 to 2011. The KNEHS is designed to collect
data every 3 years with stratified sample from around
350 survey districts for national representation. The sur-
vey included sampling of 2000 people annually. Among
the 6,311 participants of 1st KNEHS data, we excluded
2,101 participants who attended the 1st year of survey
because of lack of the value of height and weight. Add-
itionally, 539 participants met the exclusion criteria;
there were 90 participants who were not actually mea-
sured for height and weight, 448 participants with miss-
ing values of urinary 3-Phenoxybenzoic Acid (3-PBA),
and 1 participant with very extreme value of BMI. After
applying the exclusion criteria, the final study population
was 3671 participants.
Variables
12-hour urine and spot urine were collected with sterile
specimen cup for urine specimen. The specimen was de-
livered with opacity in cold storage at 4 °C, and stored
below -20 °C if the analysis was delayed. The analytes
were separated from the matrix by means of a liquid–li-
quid extraction, and Clarus 600 Perkin Elmer gas chro-
matograph equipped with a mass selective detector
(Clarus 600 T Mass Spectrometer) was used for the ana-
lysis of urinary 3-PBA. In the analysis, the limit of detec-
tion was 0.015ug/L, and the target coefficient (R2) of
calibration curve was same or more than 0.995 for internal
quality control. All urinary samples were adjusted with the
concentration of urinary creatinine to capture log-normal
distribution of urinary 3-PBA levels. Among various demo-
graphic characteristics in the survey, we chose to use sex,
age, region, current smoking and drinking status, exercise
status, education level, use of mosquitocide, and job classi-
fication. The definition of overweight and obesity were ac-
cording to WHO-WPRO criteria: ‘Underweight’ for BMI
under 18.5 kg/m2, ‘Normal’ for BMI equal or more than
18.5 kg/m2 and below 23 kg/m2, ‘Overweight’ for BMI
equal or more than 23 kg/m2 and below 25 kg/m2, and
‘Obesity’ for BMI equal or more than 25 kg/m2.
Statistical analysis
Geometric means of urinary 3-PBA were calculated ac-
cording to various demographic characteristics. Log trans-
formed urinary 3-PBA were used in the analysis due to the
right skewed pattern of distribution of urinary 3-PBA. To
evaluate the association between urinary 3-PBA and BMI,
the figures were plotted using the generalized additive
model. Since the direction of association was changed with
the increasing level of 3-PBA, piece-wise regression ana-
lysis was performed to determine the flexion point with 3
models. Model 1 was applied with simple linear regression
analysis, model 2 adjusted age and sex, and model 3 ad-
justed age, sex and other covariates; Region, current smok-
ing and drinking status, exercise status, education level,
use of mosquitocide, and job classification. Flexion point
was determined by Akaike information criterion (AIC) in
the statistical model, and regression coefficients was calcu-
lated in below and above the flexion point, respectively.
Urinary 3-PBA levels were stratified into quintiles by
their rank to estimate odds ratios (ORs) and 95 % confi-
dence intervals of prevalence for BMI-related outcomes
(‘overweight’ and ‘obesity’). Logistic regression analyses
were performed with first quintiles as the reference group.
Since participants of 1st KNEHS were selected with non-
randomized stratified method, statistical analyses were
performed using SURVEYREGRESSION and SURVEY-
LOGISTICS in SAS (Ver 9.3, SAS institute) with proposed
sample weights. Generalized additive model of R were
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used for figures, and p-values < 0.05 was considered as sta-
tistically significance.
Results
Table 1 showed the number of participants and geometric
means of urinary 3-PBA according to demographic char-
acteristics. The number of total participants was 3671 and
the geometric means of creatinine adjusted urinary 3-PBA
was 1.83 ug/g. There were 1838 male participants and
1,833 of female participants; and female participants had
higher creatinine concentration (2.10 ug/g) than male par-
ticipants (1.59 ug/g). We observed that older subjects
tended to have higher level of urinary 3-PBA, as the con-
centration of urinary 3-PBA were highest in participants
with aged above 60 i.e., 2.78 ug/g creatinine. Participants
who lived in ‘Jeju’ had the lowest level, contrastingly, sub-
jects who lived in ‘Honam’, a typical rural area in Korea,
had the highest level of urinary 3-PBA i.e., 2.39 ug/g cre-
atinine. There were 868 current smokers and 2193 partici-
pants who had a current drinking habit, and they had
higher levels. Subjects with low education level had higher
3-PBA level, and the geometric mean was 2.90 ug/g cre-
atinine. In the BMI category, participants who were over-
weight and obese had higher levels of urinary 3-PBA (1.85
ug/g creatinine for overweight; 2.05 ug/g creatinine for
obesity) than participants who had normal BMI (1.63 ug/g
creatinine). A number of subjects used mosquitocide only
in summer (N = 2,798), and subjects using mosquitocide
had higher 3-PBA concentration than subjects who did
not use mosquitocide (1.90 ug/g creatinine, for subjects
with usage only in summer; 1.58 ug/g creatinine for sub-
jects with no using mosquitocide, respectively). Lastly, in
job classification, skilled agricultural and fishery workers
had higher levels of urinary 3-PBA than subjects who had
other job classification, as 2.71 ug/g creatinine.
Figure 1 showed the association between urinary 3-PBA
and BMI levels using the generalized additive model. In
the range of urinary 3-PBA from 0 to 5 ug/g creatinine,
positive associations were observed for the total study
population. Contrastingly, in the range of urinary 3-PBA
levels above 5 ug/g creatinine, the direction of associations
were changed from positive to negative. Similar correl-
ation of increasing BMI with increasing urinary 3-PBA up
to a certain point i.e., about 5 ug/g creatinine and decrease
after that point were obtained after sex stratification.
Table 2 presented the associations between BMI and
urinary 3-PBA obtained from piece-wise regression ana-
lysis. From all of 3 models, the flexion point was deter-
mined at the value of 1.4 or 1.5 of log-transformed urinary
3-PBA, which is the same as 4.05 or 4.48 ug/g creatinine.
There were significant associations between log trans-
formed urinary 3-PBA and BMI in below and above
threshold, except at the range above flexion point in model
1(p = 0.20); and the direction of associations were changed
from positive to negative. In the analysis below the
flexion point, the regression coefficient was 0.5830
(p-value < 0.0001) in the unadjusted model (Model 1)
and 0.4004 (p-value < 0.0001) in the fully adjusted model
(Model 3). Contrastingly, regression coefficients in the
analyses performed in above flexion point was negative,
as -0.2137 in model 1. -0.3609 in model 2, and -0.3443
in model 3, respectively.
Table 3 showed the result from logistic regression ana-
lysis, and the OR and 95 % CI were calculated for over-
weight and obesity according to quintiles of 3-PBA.
When we used overweight as the outcome variables, al-
most every quintile in all models had significantly in-
creased prevalence of overweight, as compared to Q1.
Furthermore, the ORs increased till Q4, which showed
higher OR than that of Q5 (OR = 1.810, 95 % CI 1.329–
2.464 for Q4, OR = 1.483, 95 % CI 1.066–2.062 for Q5 in
model 3). This result coincided with the result of Table 2.
Q4 had the range of 2.257–4.009 ug/g of creatinine, and
the maximum of the range was almost the same as the
flexion point indicated in Table 2. Analysis using obesity
as outcome variable showed similar results as significant
positive associations between the prevalence of obesity
and almost every quintile in all models. However, there
was no difference between the OR of Q4 and that of Q5
(OR = 1.659, 95 % CI 1.211–2.273 for Q4, OR = 1.666,
95 % CI 1.245–2.230 for Q5 in model 3).
Sensitivity analyses were performed using same method
used in Tables 2 and 3 after stratification for sex and partic-
ipants aged below 60s. (The results were shown in Add-
itional file 1: Tables S1–S5) The flexion points for each sex
were 1.6 and 1.2 log-transformed urinary 3-PBA in model
3, respectively. When the analysis performed after exclu-
sion of aged above 60s, we could not find definite flexion
point. In the result of the logistic regression analysis with
stratification by sex, male participants had highest OR in
Q3 (OR= 1.958, 95 % CI 1.268–3.022 in model 3), while
that for female participants was observed in Q4 (OR =
1.942, 95 % CI 1.310–2.880 in model 3). Similar result was
obtained in obese female. Comparing with Table 3, statis-
tical significance was somewhat weaker, especially in male
participants for outcome variable as obesity; however, the
overall trend was similar. The same pattern was found in
the analysis with aged below 60s for overweight, and the
value of peak OR was 1.73 for Q4. However, the result for
outcome variable as obesity showed linear increase rather
than inverted-U shape.
Discussion
We determined the association between urinary 3-PBA
and obesity in a general adult population by using the na-
tionally representative cross-sectional study of Korea. In
conclusion, we observed a positive correlation between
urinary 3-PBA and BMI to a certain concentration level,
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and furthermore, a negative association above a certain
threshold.
In this study, we corrected urinary 3-PBA level by using
the urinary creatinine level. The geometric mean of
creatinine-corrected 3-PBA level in the whole sample was
1.83 ug/g of creatinine. In males, it was 1.59 ug/g and in fe-
males, it was 2.10 ug/g. Barr et al. studied 5,046 people
from the general population using the NHANES data of
the United States from 1999 to 2002 and reported the geo-
metric mean of the urinary 3-PBA concentration as about
0.3 ug/g of creatinine [7]. In a study on German children
[18] and on the urban population of Poland [19], the levels
were reportedly 0.24 ug/g of creatinine and 0.327 ug/g of
creatinine, respectively, showing a marked difference from
the results of this study. Meanwhile, among the studies that
have targeted Asian countries, Ueyama et al., measured the
3-PBA levels of 535 people from Japan’s middle aged and
elderly population [20]. They reported that the geometric
mean of urinary 3-PBA concentration was 0.73 ug/g of cre-
atinine, which was higher in males (0.59 ug/g of creatinine)
than in females (0.80 ug/g of creatinine). Another group re-
ported a median value of 1.55 ug/g of creatinine in 1,149
pregnant women from an agricultural area of the Province
of Jiangsu, China, which was similar to the results from our
study [21]. There was little studies about urinary 3-PBA
targeted to Korean subjects, but a recent population survey
revealed the median concentration of 3-PBA was 1.06 ug/g
for male subjects and 1.54 for female subjects [22]. This
level of 3-PBA was also higher than other studies con-
ducted in general population from the US or EU countries.
Up to now, the reason why Korean has higher urinary 3-
PBA level than other countries are in question. Our as-
sumption is that most Koreans were widely exposed to
various form of pyrethroid insecticide such as spray and fu-
migant. Among them, using fumigant insecticide at home
is unique form of pyrethroid exposure and has possible
common source to general population in Korea. Further-
more, many product including pyrethroid is being adver-
tised as ‘eco-friendly’ product, which has meaning of ‘not
toxic’, not as ‘less toxic’.
Table 1 General characteristics of study population and




N Geometric mean Geometric SD
Total 3671 1.83 2.71
Sex
Male 1838 1.59 2.66
Female 1833 2.10 2.70
Age
19–29 448 0.95 2.41
30–39 696 1.25 2.50
40–49 835 1.69 2.37
50–59 902 2.42 2.46





Chungchong 458 1.85 2.59
Honam 466 2.39 2.77
Yongnam 1185 1.86 2.72
Jeju 95 1.36 1.99
Current Smoking
No 2803 1.95 2.73
Yes 868 1.47 2.56
Current Drinking
No 1478 2.16 2.72
Yes 2193 1.63 2.66
Regular Exercise
No 2048 1.83 2.76
Yes 1060 1.93 2.65
Irregular exercise 563 1.64 2.60
Education
Middle school 1113 2.90 2.69
High school 1245 1.80 2.51
College 1313 1.25 2.47
BMI(kg/m2)
< 18.5 100 1.28 2.88
18.5 to < 23 1232 1.63 2.79
23 to < 25 886 1.85 2.68
25 ≤ 1453 2.05 2.60
Use of Mosquitocide
No 826 1.58 2.63
Only summer 2798 1.90 2.73
All year around 36 2.06 2.22
Summer, winter 11 1.83 2.10
Table 1 General characteristics of study population and






aIndoor worker 1103 1.48 2.54
bOutdoor worker 846 1.78 2.44
cOthers 1338 1.97 2.80
aIndoor worker : Legislators, senior officials and managers, Professionals,
Clerks, Service workers and shop and market sales workers
bOutdoor worker : Craft and related trades workers, Plant and machine
operators and assemblers, Elementary occupations, Armed forces
cOthers : Housewives, Students, Unknown
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Recently, ongoing research has focused on the associa-
tions between obesity and endocrine disrupting chemicals
besides pyrethroids. Most studies for dichlorodiphenyldi-
chloroethylene(DDE) were reported with positive associa-
tions with obesity in either cross-sectional or prospective
study design [23–26]. While studies about polychlorinated
biphenyl(PCB) had inconsistent results of non-significant
associations [25–27], positive [28], or inverse associations
[29–31]. To overcome these limitations of linearity, some
reports argued non-monotonous dose–response (NMDR)
relationships between the concentrations of chemicals and
body weight [13–15, 17]. That is, inverted U-shaped curve
might be more suitable than linearity. One recent pro-
spective study by Lee et al. showed that low dose of p,p’-
DDE, p,p’-DDT, and some PCB were associated with BMI
in inverted U-shaped relationships [14]. Furthermore,
inverted U-shaped responses to exposure of various POPs
were observed in dyslipidemia, diabetes and insulin resist-
ance [14, 17]. As known in their name, these chemicals
had toxic effect with their persistency in the body. Bisphe-
nol A had a distinct characteristic with these chemicals, as
short half-life in humans as less than 6 h similar as pyreth-
roid. Nevertheless, BPA is well known endocrine disruptor
to human and one study reported nonlinear relationships
in BMI in the elderly using panel study [32]. In this study,
as the concentration of bisphenol A increased, the ORs
for overweight showed a corresponding increase at low
levels of exposure, however, the response plateaued at
high level exposure in total and female subjects. Biological
pathway between BPA and obesity were explained as BPA
acts through phosphatidylinositol 3-kinase, resulting in ac-
celerated terminal adipocyte differentiation [33], and stim-
ulates triacylglycerol accumulation in mature adipocytes
[34]. Some suggested other possible mechanisms that sup-
pression of adiponectin release and a change in hypothal-
amic action [35, 36]. Some animal studies showed high
dose exposure to bisphenol A caused weight loss [37].
Similar to our results, there are studies on animals that
show an association between high-exposure to pyrethroid
and changes in body weight. According to the toxicological
profile for pyrethrins and pyrethroids by ATSDR, a study
reported that rats who consumed 250 mg/kg/day of total
pyrethrins for 104 weeks lost body weight, and dogs who
consumed 12.5 mg/kg/day of fenpropathrin for 3 months
had reduced weight gain [12]. Other studies have also re-
ported that intermediate or chronic duration of pyrethrin
consumption caused a reduced body weight or body weight
gain. However, to our best knowledge, there has been no
report on the association between pyrethroids and
weight change in human. Only some animal studies in-
dicate that high experimental dosage cause weight loss
in animals [38, 39]. However, although direct evidence
Fig. 1 Association between urinary 3-PBA and BMI levels using generalized additive models, among (a) the total, (b) the male and (c) the female
participants. The model was adjusted for age, sex, region, current smoking and drinking status, exercise status, education level, use of mosquitocide,
and job classification




Below flexion point After flexion point
Beta-estimate (SE) P value Beta-estimate (SE) P value
Model 1 1.4 0.5830 (0.0769) < 0.0001 −0.2137 (0.1679) 0.20
Model 2 1.5 0.4038 (0.0786) < 0.0001 −0.3609 (0.1792) 0.04
Model 3 1.4 0.4004 (0.0820) < 0.0001 −0.3443 (0.1679) 0.04
*Model 1 : Crude
Model 2 : Sex, age adjusted
Model 3 : Sex, age, region, current smoking status, current drinking status, regular exercise, education, use of mosquitocide, and job classification adjusted
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on influence of low level exposure of pyrethroids on
human is not available, we can infer the relation using
analogy from some chemicals having similar lipophilic
property to 3-PBA. In line with findings of NMDR rela-
tionships on bisphenol A, we assume that 3-PBA act
like obesogen in low level exposure while behave like
toxin in high level exposure. Therefore, we might have
significant results due to lipophilic character of pyre-
throids in low level exposure and also have inverted U-
shaped pattern due to different action depending on
the dosage.
There are 2 potential biological mechanisms for pyreth-
roid mediated effect on body weight. First is affecting the
neurological system. The main mechanism is the sodium
channels blocking effect of pyrethroids in the nervous sys-
tem. In animal studies, among nerve tissues, pyrethroid
was found to be most highly concentrated in sciatic
nerves, then in the order of hypothalamus, frontal cortex,
hippocampus, and caudate putamen. Among these, hypo-
thalamus is a well-known central appetite control center
[40–42], and various studies describe hippocampus as
having an effect on energy intake and body weight regula-
tion [43–45]. Also, Hossain et al. reported that pyrethroid
has an effect on the secretion of acetylcholine from hippo-
campus [46]. Their results suggest the possibilities of
weight change on pyrethroid exposure through disturbing
the central appetite control centers such as hypothalamus
and hippocampus. The second mechanism involves the en-
docrinologic effects of pyrethroid. Many pesticides act as
endocrine disrupting chemicals, and pyrethroid reportedly
causes estrogenic responses [47, 48]. As a result, pyrethroid
exposure could cause weight gain through stimulating adi-
pocytes and affecting insulin regulation, similar to other
substances with estrogenic responses [49, 50].
Our research had several limitations. First, the 1st
KNEHS utilizes the data from a cross-sectional study de-
sign, which cannot propose a causal relation. Addition-
ally, the half-life of pyrethroids was known as few hours.
According to ATSDR, when type II pyrethroids were ex-
posed from oral route, the elimination half-time based
on the appearance of metabolites in the urine has been
estimated to be between 6 and 13 h. Exposure misclassifica-
tion may occur due to short biologic half-life of pyrethroid
depending on the interval between pyrethroid exposure
and time of urine collection, so the result might have a bias
that tends toward the null. That is, significant association
between pyrethroid exposure and obesity in our analysis
might be underestimated. Furthermore, from the point of
distribution of pyrethroid in our body after absorption, py-
rethroids are rapidly distributed in the adipose tissue, liver,
kidneys and the nervous system. So, there was a possibility
that participants who had high BMI could get high urinary
3-PBA due to distribution of pyrethroid in the body. Even
though some experimental animal studies showed that ob-
served body weight was changed after administration of
pyrethroid, our study does not provide clear temporal rela-
tionship between pyrethroid exposure and obesity. Further
longitudinal design of study for human is required to con-
firm causal relation. Second, overweight or obesity which
was used in our analysis as outcome variables, had highly
Table 3 OR and 95 % CI for BMI related outcomes according to quintiles of urinary 3-PBA
< Overweight >
Quintiles of 3-PBA Model 1 Model 2 Model 3
OR 95 % CI OR 95 % CI OR 95 % CI
Q1 Ref Ref Ref
Q2 1.481 1.114–1.970 1.311 0.980–1.755 1.339 0.993–1.806
Q3 1.841 1.395–2.428 1.535 1.143–2.061 1.503 1.113–2.031
Q4 2.256 1.715–2.968 1.813 1.346–2.441 1.810 1.329–2.464
Q5 2.020 1.534–2.662 1.508 1.103–2.060 1.483 1.066–2.062
< Obesity >
Quintiles of 3-PBA Model 1 Model 2 Model 3
OR 95 % CI OR 95 % CI OR 95 % CI
Q1 Ref Ref Ref
Q2 1.384 1.056–1.813 1.263 0.955–1.671 1.277 0.970–1.682
Q3 1.840 1.408–2.405 1.613 1.218–2.137 1.606 1.228–2.100
Q4 1.945 1.454–2.603 1.656 1.201–2.282 1.659 1.211–2.273
Q5 2.100 1.605–2.748 1.715 1.274–2.308 1.666 1.245–2.230
*Range of quintiles: Q1 0.032–0.797, Q2 0.800–1.386, Q3 1.387–2.256, Q4 2.257–4.009, Q5 4.027–261.252
Model 1 : Crude
Model 2 : Sex, age adjusted
Model 3 : Sex, age, region, current smoking status, current drinking status, regular exercise, education, use of mosquitocide, and job classification adjusted
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associated with calorie intake, but our study could not con-
sider calorie intake because of lack of data. Other life style
factors such as alcohol drinking or regular exercise status
were considered in our analysis, although the information
were given as simply ‘Yes’ or ‘No’. Last, this study evaluated
pyrethroid exposure with urinary 3-PBA alone. We did not
have any information on urinary metabolites of pyrethroid
other than 3-PBA, including cis- and trans-DCCA, 4-
fluoro-3-phenoxybenzoic acid (4F3PBA). However, urinary
3-PBA is a metabolite of various pyrethroids (permethrin,
cypermethrin, deltamethrin, allethrin, resmethrin, fenvale-
rate, etc.), which enables the assessment of pyrethroid ex-
posure. In spite of these limitations, our study has some
strength. First, sample size of our study was larger than any
studies for pyrethroid exposure to human in Korea. Second,
the 1st KNEHS was designed to have national representa-
tion for general population using stratified multistage prob-
ability sampling method. However, further longitudinal
studies will be required to clarify the causal relationship be-
tween pyrethroid exposure and obesity.
Conclusions
In conclusion, we identified a positive correlation between
low level of urinary 3-PBA and BMI, and a negative associ-
ation above a certain threshold. Pyrethroids are frequently
used not only in agricultural areas, but also in the urban
areas, hence appropriate management of pyrethroids is
required.
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